Could mosquitoes deliver vaccines against malaria?

Sat Dec 21 07:36:24 UTC 2024: ## Mosquitoes Deliver Malaria Vaccine in Promising Clinical Trial

**Amsterdam, Netherlands** – A groundbreaking clinical trial conducted by researchers at Leiden University Medical Center (LUMC) and Radboud University has demonstrated the potential of using genetically modified mosquitoes to deliver a malaria vaccine. The study, published in the *New England Journal of Medicine*, showed a significantly higher rate of malaria immunity in participants who received the vaccine delivered via mosquito bites compared to a placebo group.

The vaccine employs a weakened strain of the *Plasmodium falciparum* parasite, the cause of the deadliest form of malaria. Researchers modified the parasite, disabling a key gene that prevents it from causing illness while still triggering an immune response. In the trial, mosquitoes carrying this modified parasite delivered the vaccine through bites, mimicking natural malaria transmission.

Two versions of the vaccine, GA1 and GA2, were tested. While GA1 provided some protection, the GA2 vaccine showed a remarkable 89% success rate in inducing immunity against malaria in the 20 participants. No participants in the placebo group developed immunity.

Lead researcher Professor Meta Roestenberg emphasized that the mosquito delivery method is a promising approach for ease and speed of delivery, particularly in resource-limited settings. However, she noted that this method is not scalable for widespread use and that the vaccine will need to be developed into a vialled form for broader implementation in malaria-endemic regions.

While the results are encouraging, the researchers acknowledge that larger-scale trials are needed to confirm the efficacy and long-term protection offered by the GA2 vaccine, especially against diverse malaria strains. This innovative approach builds upon previous research exploring the use of insects as vaccine delivery systems, highlighting a potential game-changer in the fight against this deadly disease. The high success rate of the GA2 vaccine offers significant hope for a novel and potentially more effective malaria prevention strategy.